Q&A

Nebulized 3% saline effective for viral bronchiolitis

Author and Disclosure Information

  • BACKGROUND: Viral bronchiolitis is a common cause of illness in children aged <24 months. Studies have found no benefit in treatment with steroids or ribavirin. A Cochrane review of bronchodilators for the treatment of bronchiolitis showed only modest short-term improvement in clinical scores, which must be weighed against side effects. Hypertonic saline solution, by absorbing water from the submucosa, can theoretically reverse some of the bronchiolar edema.
  • POPULATION STUDIED: The authors studied 70 infants under the age of 24 months who presented to an ambulatory pediatric clinic with a clinical presentation of mild-to-moderate bronchiolitis. Infants were excluded if they had any cardiac or chronic respiratory illness, previous wheezing episode, oxygen saturation <96% on room air, or need for hospitalization.
  • STUDY DESIGN AND VALIDITY: In this double-blinded, randomized study, infants were assigned to either a control or treatment group. The control group received inhalations of 0.5 mL (5 mg) terbutaline in 2 mL of 0.9% saline solution as a wet nebulized aerosol, while the treatment group received inhalations of the same dose of terbutaline in 2 mL of 3% saline solution. Infants in both groups were given 3 treatments per day (every 8 hours) for 5 days.
  • OUTCOMES MEASURED: The examiners compared the change in a 12-point clinical severity score over a 5-day course of treatment. The rate of hospitalization in each group was also measured.
  • RESULTS: The clinical severity of each group was similar at the beginning of the study (6.4 for the control group and 6.6 for the treatment group). After day 1, the clinical severity score before inhalation therapy was significantly better (P<.005) in the treatment group than the control group (day 2, 3.9 vs 5.2; day 3, 2.1 vs 4.8; day 4, 1.1 vs 3.8; day 5, 0.9 vs 2.9).


 

PRACTICE RECOMMENDATIONS

This small, poorly described study suggests that nebulized 3% hypertonic saline improves outcomes for nonhospitalized infants with bronchiolitis more than the use of normal saline.

While this study has significant flaws, the intervention appears safe. It would be reasonable to use nebulized 3% saline while waiting for larger, better studies.

Recommended Reading

Should patients with acute cough or bronchitis be treated with β2-agonists?
MDedge Family Medicine
How accurate is the D-dimer assay in diagnosing pulmonary embolism?
MDedge Family Medicine
Clinical Findings Associated with Radiographic Pneumonia in Nursing Home Residents
MDedge Family Medicine
Are b2-agonists Effective Treatment for Acute Bronchitis or Acute Cough in Patients Without Underlying Pulmonary Disease? A Systematic Review
MDedge Family Medicine
Can helical computerized tomography be used alone to aid in the diagnosis of patients with suspected pulmonary embolism?
MDedge Family Medicine
Azithromycin no more effective than vitamin C for acute bronchitis
MDedge Family Medicine
Inhaled salmeterol prevents high-altitude pulmonary edema
MDedge Family Medicine
Vitamin E may worsen acute respiratory tract infections in the elderly
MDedge Family Medicine
Nortriptyline effective for smoking cessation
MDedge Family Medicine
Negative ELISA D-dimer assay can miss pulmonary embolism
MDedge Family Medicine